Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Cited In for PubMed (Select 20876603)

1.

Predictors of atrial fibrillation recurrence after cryoballoon ablation.

Aksu T, Baysal E, Guler TE, Golcuk SE, Erden İ, Ozcan KS.

J Blood Med. 2015 Jun 29;6:211-7. doi: 10.2147/JBM.S81551. eCollection 2015.

2.
3.

Age and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation.

Hung CY, Hsieh YC, Li CH, Huang JL, Lin CH, Wu TJ.

Sci Rep. 2015 Jun 22;5:11442. doi: 10.1038/srep11442.

4.

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.

Ment J.

Vasc Health Risk Manag. 2015 Jun 10;11:317-32. doi: 10.2147/VHRM.S79065. eCollection 2015. Review.

5.

Risk and outcome after ablation of isthmus-dependent atrial flutter in elderly patients.

Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D, De Chillou C, Lamiral Z, Girerd N.

PLoS One. 2015 May 22;10(5):e0127672. doi: 10.1371/journal.pone.0127672. eCollection 2015.

6.

Inappropriate use of digoxin in patients presenting with digoxin toxicity.

Tatlisu MA, Ozcan KS, Gungor B, Zengin A, Karatas MB, Nurkalem Z.

J Geriatr Cardiol. 2015 Mar;12(2):143-6. doi: 10.11909/j.issn.1671-5411.2015.02.007.

7.

CHADS2 and CHA2DS2-VASc scoring systems for predicting atrial fibrillation following cardiac valve surgery.

Yin L, Ling X, Zhang Y, Shen H, Min J, Xi W, Wang J, Wang Z.

PLoS One. 2015 Apr 7;10(4):e0123858. doi: 10.1371/journal.pone.0123858. eCollection 2015.

8.

Percutaneous left atrial appendage closure: Technical aspects and prevention of periprocedural complications with the watchman device.

Möbius-Winkler S, Majunke N, Sandri M, Mangner N, Linke A, Stone GW, Dähnert I, Schuler G, Sick PB.

World J Cardiol. 2015 Feb 26;7(2):65-75. doi: 10.4330/wjc.v7.i2.65. Review.

9.

Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.

Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M.

J Am Heart Assoc. 2015 Jan 21;4(1):e001486. doi: 10.1161/JAHA.114.001486.

10.

Catheter ablation of atrial fibrillation in the elderly.

Lioni L, Letsas KP, Efremidis M, Vlachos K, Giannopoulos G, Kareliotis V, Deftereos S, Sideris A.

J Geriatr Cardiol. 2014 Dec;11(4):291-5. doi: 10.11909/j.issn.1671-5411.2014.04.003.

11.

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study.

Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Östgren CJ, Sundström J.

Cardiovasc Diabetol. 2015 Jan 15;14:5. doi: 10.1186/s12933-014-0170-3.

12.

Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.

Huang B, Yang Y, Zhu J, Liang Y, Zhang H, Tian L, Shao X, Wang J.

Yonsei Med J. 2015 Jan;56(1):62-71. doi: 10.3349/ymj.2015.56.1.62.

13.

Characterization of patients with atrial fibrillation not treated with oral anticoagulants.

Johansson C, Hägg L, Johansson L, Jansson JH.

Scand J Prim Health Care. 2014 Dec;32(4):226-31. doi: 10.3109/02813432.2014.984952. Epub 2014 Dec 3.

14.

Differences in quality of life, anxiety and depression in patients with paroxysmal atrial fibrillation and common forms of atrioventricular reentry supraventricular tachycardias.

Lioni L, Vlachos K, Letsas KP, Efremidis M, Karlis D, Asvestas D, Kareliotis V, Xydonas S, Dimopoulos N, Korantzopoulos P, Trikas A, Sideris A.

Indian Pacing Electrophysiol J. 2014 Oct 6;14(5):250-7. eCollection 2014 Sep.

15.

A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population.

Cao H, Zhou Q, Lan R, Røe OD, Chen X, Chen Y, Wang D.

PLoS One. 2014 Nov 17;9(11):e112912. doi: 10.1371/journal.pone.0112912. eCollection 2014.

16.

Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation.

Kornej J, Dinov B, Blann AD, Rolf S, Arya A, Schmidl J, Husser D, Hindricks G, Bollmann A, Lip GY.

PLoS One. 2014 Nov 12;9(11):e111760. doi: 10.1371/journal.pone.0111760. eCollection 2014.

17.

Atrial fibrillation in decompensated heart failure: associated factors and in-hospital outcome.

Mendes Fde S, Atié J, Garcia MI, Gripp Ede A, Sousa AS, Feijó LA, Xavier SS.

Arq Bras Cardiol. 2014 Oct;103(4):315-22. Epub 2014 Aug 29. English, Portuguese.

18.

Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?

Denoël P, Vanderstraeten J, Mols P, Pepersack T.

J Aging Res. 2014;2014:693740. doi: 10.1155/2014/693740. Epub 2014 Sep 10.

19.

Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation.

Sen S, Dahlberg KW.

Am J Med Sci. 2014 Dec;348(6):513-21. doi: 10.1097/MAJ.0000000000000349. Review.

20.

Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocol.

Gunnell AS, Knuiman MW, Geelhoed E, Hobbs MS, Katzenellenbogen JM, Hung J, Rankin JM, Nedkoff L, Briffa TG, Ortiz M, Gillies M, Cordingley A, Messer M, Gardner C, Lopez D, Atkins E, Mai Q, Sanfilippo FM.

BMJ Open. 2014 Sep 18;4(9):e006258. doi: 10.1136/bmjopen-2014-006258.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk